Noori, S, McCoy, M, Friedlich, P, et al. Failure of ductus arteriosus closure is associated with increased mortality in preterm infants. Pediatrics
2009; 123: e138–e144.
Benitz, WE. Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis?
2010; 30: 241–252.
Sellmer, A, Bjerre, JV, Schmidt, MR, et al. Morbidity and mortality in preterm neonates with patent ductus arteriosus on day 3. Arch Dis Child Fetal Neonatal Ed
2013; 98: F505–F510.
Benitz, WE. Patent ductus arteriosus in preterm infants. Pediatrics
2016; 137: 1–6.
Gournay, V, Roze, JC, Kuster, A, et al. Prophylactic ibuprofen versus placebo in very premature infants: a randomised, double-blind, placebo-controlled trial. Lancet
2004; 364: 1939–1944.
Gudmundsdottir, A, Johansson, S, Hakansson, S, Norman, M, Kallen, K, Bonamy, AK. Timing of pharmacological treatment for patent ductus arteriosus and risk of secondary surgery, death or bronchopulmonary dysplasia: a population-based cohort study of extremely preterm infants. Neonatology
2015; 107: 87–92.
Baylen, BG, Meyer, RA, Kaplan, S, Ringenburg, WE, Korfhagen, J. The critically ill premature infant with patent ductus arteriosus and pulmonary disease-an echocardiographic assessment. J Pediatr
1975; 86: 423–432.
DeMauro, SB, Cohen, MS, Ratcliffe, SJ, Abbasi, S, Schmidt, B. Serial echocardiography in very preterm infants: a pilot randomized trial. Acta Paediatr
2013; 102: 1048–1053.
Van Overmeire, B, Van de Broek, H, Van Laer, P, Weyler, J, Vanhaesebrouck, P. Early versus late indomethacin treatment for patent ductus arteriosus in premature infants with respiratory distress syndrome. J Pediatr
2001; 138: 205–211.
Roze, JC, Cambonie, G, Marchand-Martin, L, et al. Association between early screening for patent ductus arteriosus and in-hospital mortality among extremely preterm infants. JAMA
2015; 313: 2441–2448.
Spitzer, AR, Ellsbury, DL, Handler, D, Clark, RH. The Pediatrix BabySteps Data Warehouse and the Pediatrix QualitySteps improvement project system – tools for “meaningful use” in continuous quality improvement. Clin Perinatol
2010; 37: 49–70.
Trembath, A, Hornik, CP, Clark, R, Smith, PB, Daniels, J, Laughon, M. Comparative effectiveness of surfactant preparations in premature infants. J Pediatr
2013; 163: 955–960.e1.
Kliegman, RM, Walsh, MC. Neonatal necrotizing enterocolitis: pathogenesis, classification, and spectrum of illness. Curr Probl Pediatr
1987; 17: 213–288.
Hamrick, SE, Hansmann, G. Patent ductus arteriosus of the preterm infant. Pediatrics
2010; 125: 1020–1030.
Jones, LJ, Craven, PD, Attia, J, Thakkinstian, A, Wright, I. Network meta-analysis of indomethacin versus ibuprofen versus placebo for PDA in preterm infants. Arch Dis Child Fetal Neonatal Ed
2011; 96: F45–F52.
Gudmundsdottir, A, Johansson, S, Hakansson, S, Norman, M, Kallen, K, Bonamy, AK. The importance of echocardiography and an individual approach to patent ductus arteriosus treatment in extremely preterm infants. Neonatology
2015; 107: 257.
Kluckow, M, Evans, N. Early echocardiographic prediction of symptomatic patent ductus arteriosus in preterm infants undergoing mechanical ventilation. J Pediatr
1995; 127: 774–779.
Alagarsamy, S, Chhabra, M, Gudavalli, M, Nadroo, AM, Sutija, VG, Yugrakh, D. Comparison of clinical criteria with echocardiographic findings in diagnosing PDA in preterm infants. J Perinat Med
2005; 33: 161–164.
McNamara, PJ, Sehgal, A. Towards rational management of the patent ductus arteriosus: the need for disease staging. Arch Dis Child Fetal Neonatal Ed
2007; 92: F424–F427.
El-Khuffash, AF, Slevin, M, McNamara, PJ, Molloy, EJ. Troponin T, N-terminal pro natriuretic peptide and a patent ductus arteriosus scoring system predict death before discharge or neurodevelopmental outcome at 2 years in preterm infants. Arch Dis Child Fetal Neonatal Ed
2011; 96: F133–F137.
Kadivar, M, Kiani, A, Kocharian, A, Shabanian, R, Nasehi, L, Ghajarzadeh, M. Echocardiography and management of sick neonates in the intensive care unit. Congenit Heart Dis
2008; 3: 325–329.
Schachinger, S, Stansfield, RB, Ensing, G, Schumacher, R. The prevalence of and attitudes toward neonatal functional echocardiography use and training in the United States: a survey of neonatal intensive care unit medical directors. J Neonatal Perinatal Med
2014; 7: 125–130.
de Waal, K, Kluckow, M. Functional echocardiography; from physiology to treatment. Early Hum Dev
2010; 86: 149–154.
Shah, DM, Kluckow, M. Early functional echocardiogram and inhaled nitric oxide: usefulness in managing neonates born following extreme preterm premature rupture of membranes (PPROM). J Paediatr Child Health
2011; 47: 340–345.
Christmann, V, Liem, KD, Semmekrot, BA, van de Bor, M. Changes in cerebral, renal and mesenteric blood flow velocity during continuous and bolus infusion of indomethacin. Acta Paediatr
2002; 91: 440–446.
Mirea, L, Sankaran, K, Seshia, M, et al. Treatment of patent ductus arteriosus and neonatal mortality/morbidities: adjustment for treatment selection bias. J Pediatr
2012; 161: 689–694.e1.
Letshwiti, JB, Semberova, J, Pichova, K, Dempsey, EM, Franklin, OM, Miletin, J. A conservative treatment of patent ductus arteriosus in very low birth weight infants. Early Hum Dev
2017; 104: 45–49.